Abingdon Health Plc (LON:ABDX – Get Free Report) dropped 2.2% during trading on Wednesday . The company traded as low as GBX 11 and last traded at GBX 11. Approximately 8,378 shares traded hands during mid-day trading, a decline of 97% from the average session volume of 303,568 shares. The stock had previously closed at GBX 11.25.
Abingdon Health Stock Down 1.0%
The company has a debt-to-equity ratio of 15.05, a current ratio of 1.91 and a quick ratio of 1.96. The company has a market capitalization of £25.48 million, a P/E ratio of -12.53 and a beta of 0.18. The stock has a 50-day moving average price of GBX 11.29 and a 200-day moving average price of GBX 8.43.
Abingdon Health Company Profile
Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.
Read More
- Five stocks we like better than Abingdon Health
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
- AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
- Palantir’s Valuation Problem Just Met 2 New Growth Catalysts
- Xcel Energy Stock Offers Stability as Electricity Demand Builds
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.
